摘要
目的探讨延伸因子1a(EF-1α)基因表达与前列腺癌细胞株DU145细胞增殖、克隆形成等功能的关系。方法DU145细胞株分3组:对照组(未转染siRNA),转染对照组(转染随机siRNA)和实验组(转染EF-1α—siRNA)。应用RNA干扰技术特异性调低DU145细胞株EF-1α蛋白质水平,并通过蛋白质印迹法验证。应用体外细胞功能分析技术,比较EF-1α蛋白质水平调低后DU145细胞增殖、克隆形成能力的变化和差异。结果应用RNA干扰技术实现了特异性调低前列腺癌细胞株DU145中EF-1α的水平。转染随机siRNA不影响DU145细胞中EF-1α蛋白质水平。调低DU145细胞EF-1α蛋白质水平后,实验组DU145细胞第4~7天增殖率较对照组下降45.9%、53.5%、35.3oA和38.1%(P〈0.05)。实验组DU145细胞形成克隆数较对照组减少67.0%(P〈0.01)。结论调低EF-1α表达水平对前列腺癌细胞增殖、克隆形成等肿瘤相关生物学行为产生负面影响。Ep-1α基因在前列腺癌靶向治疗中可能成为适当的靶基因。
Objective To study the elongation factor 1α(EF-1α) gene functions in prostate cancer cell line DU145 in the aspects of cell proliferation and clone formation by using the RNA interfer- ence technique. Methods DU145 cell lines were divided into control group, transfection control group transfected with scramble siRNA and experimental group transfected with EF-1α siRNA. After transfecting EF-1α siRNA into DU145 cell line, the down-regulation of EF-1α expression in DU145 cell line was confirmed by Western blotting and immunofluorescence staining. Then, the cell proliferation and clone formation assays were carried on in these 3 groups of DU145 cells. Results Compared with controls, the specific down-regulation of EF-1α expression was achieved in experimental group only. Compared with control group, after the down-regualtion of EF-1α in DU145 cell line, the cell proliferation rate decreased from day 4 to day 7 after transfection by 45.9%, 53.5%, 35.3% and 38. 1%, respectively(P〈0.05). The clone formation number in experimental group decreased by 67.0 (P〈0.01). Conclusions The down-regulation of EF-1α has a negative impact on prostate cancer cell proliferation and clone formation. EF-1α might be an appropiate targeting gene in prostate cancer targeting therapy.
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2010年第3期203-206,共4页
Chinese Journal of Urology
基金
国家自然科学基金资助项目(C03030305)
关键词
肽延伸因子1
RNA干扰
前列腺肿瘤
克隆
分子
细胞增殖
Peptide elongation factor 1
RNA interference
Prostatic neoplasms
Cloning,molecular
Cell proliferation